There’s Yelp, Urbanspoon, Rate My Professor and TripAdvisor, just to name a few. But why are there no trusted doctor review websites? HealthGrades and a few other sites have tried but lack participation.
The NYT‘s Ron Lieber proposes that it’s a supply and demand issue: Consumers would trust sites with more robust reviews, but not enough people take the time to review their doctors. And why is that? Some possibilities, according to Lieber: many people idolize their doctors, and others live in small towns where they don’t want to badmouth their doctors. But what it really may come down to is that, “to advise people anonymously through an open site when this is an important decision for people’s lives, I don’t think it’s proper,” one doctor was quoted saying.
AstraZeneca (NYSE:AZN) is suing the Food and Drug Administration with the hope of extending its exclusivity rights on the depression drug Seroquel, its second-best selling drug. The FDA denied a petition filed by the company last week proposing that generic copies of the drug would need to be labeled with the same warnings about possible side effects as AstraZeneca.
Biotech stocks’ hot streak seems to have come to a halt, as disappointing clinical trial results and FDA approval failures have sent Tranzyme Pharma, Anthera Pharmaceuticals, Oncothyreon and NeurogesX, just to name a few, plummeting. But still, the Nasdaq Biotech Index is up 14 percent for the year.
Scientists at the FDA in general feel better about the political and corporate affairs they witness at the regulatory agency now versus a few years ago, according to a new survey conducted by the Union of Concerned Scientists. However, the percentage of them (one-fourth) who feel too intimidated to speak up when they see political or corporate meddling that interferes with the agency’s mission hasn’t changed.
In a survey of 115 medical residents at the University of Chicago Medical Center, researchers found that allowing the medical students to use tablets in the clinical setting resulted in them completing 8 percent more orders by the end of their shifts. Almost 80 percent of participants said the iPad made them feel more efficient, and 68 percent said it prevent delays in patient care.